Table 3.2 of Annex VI of CLP Regulation was thought to be a straightforward “cut and paste” from Annex I of the Dangerous Substance Directive. It is not. Companies should verify carefully the status of their substances under Annex VI, Table 3.2.The UK Competent Authority promises to be pragmatic and proportionate in dealing with this issue.